The present invention relates to novel cycloalkylidene carboxylic acids and derivatives thereof useful as Bruton tyrosine kinase (BTK) inhibitors. The present disclosure also relates to processes for their preparation, pharmaceutical compositions containing one or more such compounds, and to the use of such compounds and pharmaceutical compositions for the treatment of disorders involving mediation of BTK in humans (Formula I).
本发明涉及一种新型的环烷基亚甲基
羧酸及其衍
生物,可用作布鲁顿
酪氨酸激酶(BTK)
抑制剂。本公开还涉及其制备方法,含有一种或多种此类化合物的药物组合物,以及利用这些化合物和药物组合物治疗涉及BTK介导的人类疾病的用途(
化学式I)。